GMP Annex 1 Implementation How RTU containers can be a suitable, time-efficient and cost-effective answer to meet new regulation requirements
EducationalHow to manage the revision of cGMPs Annex 01 for sterile products
2025-06-04 | 01:00 PM - 01:15 PM | TPD Room
Information
The latest trends shaping the pharmaceutical industry are all about innovation—developing cutting-edge drugs, boosting production capacity, and driving down costs, all while adhering to the requirements of EU GMP Annex 1 to handle critical manufacturing steps and manage risks associated with contamination.
With these goals in mind, this presentation will explore the most innovative sterile primary packaging solutions designed to meet the needs of a fast-evolving market. These solutions not only enable quick adaptation to the latest GMP requirements but also help minimize non-quality costs and potential risks of contamination and enhance the efficiency of the fill-and-finish process, allowing pharma companies and CMOs to focus on core activities.
Additionally, we’ll highlight the benefits for pharmaceutical companies in adopting RTU containers, including the principles of sustainability: RTU containers support a production model that aligns with the new European regulations on packaging and packaging waste, offering a future-focused approach to the pharmaceutical industry’s evolving landscape.
